ad image

Sanofi

1 / 3
Sanofi
COVID-19 Vaccine

Sanofi and GSK COVID-19 Vaccine Candidate Demonstrates Strong Immune Responses Across All Adult Age Groups in Phase 2 Trial

Sanofi

PR-M05-21-011May 17, 2021
Sanofi
Vaccine Manufacturing

Sanofi to Help Manufacture Moderna's COVID-19 Vaccine

Sanofi

PR-M04-21-029-1015Apr 27, 2021
Sanofi
M&A

Sanofi Acquires Tidal Therapeutics and Adds an mRNA-Based Research Platform

Sanofi

PR-M04-21-012Apr 14, 2021
Sanofi
Manufacturing

Sanofi to Invest in Vaccine Production Site in Singapore

Sanofi

PR-M04-21-011Apr 13, 2021
GSK
COVID-19 Vaccine

Sanofi and GSK to Support COVAX with 200 Million Doses of COVID-19 Vaccine

GSK

PR-M10-20-18Oct 28, 2020
Sanofi
COVID-19 Vaccine Funding

Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 Vaccine

Sanofi

PR-M08-20-NI-05Jul 31, 2020
Sanofi
Strategic Partnership

Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients

Sanofi

PR-M07-20-NI-013Jul 10, 2020
Sanofi
Collaboration

Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines Across All Infectious Disease Areas

Sanofi

PR-M06-20-NI-027Jun 23, 2020
Sanofi
COVID-19 Clinical Trial

Sanofi and Regeneron Provide Update on U.S. Phase 2/3 Adaptive-Designed Trial in Hospitalized COVID-19 Patients

Sanofi

PR-M04-20-NI-040Apr 28, 2020
Sanofi
FDA Approval

FDA Approves New Meningococcal Vaccination

Sanofi

PR-M04-20-NI-041Apr 28, 2020
Sanofi
COVID-19 Self-Testing

Sanofi and Luminostics to Join Forces on Developing COVID-19 Smartphone-based Self-Testing Solution

Sanofi

PR-M04-20-NI-030Apr 20, 2020
Sanofi

Sanofi and GSK to Join Forces in COVID-19 Vaccine Collaboration

Sanofi

PR-M04-20-NI-020Apr 14, 2020
Sanofi to Exit Diabetes and Cardiovascular Research
Diabetes

Sanofi to Exit Diabetes and Cardiovascular Research

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M12-19-NI-005Dec 13, 2019
Sanofi
M&A

Sanofi to Acquire Synthorx to Bolster its Immuno-Oncology Pipeline for $2.5 Billion

Sanofi

PR-M12-19-NI-016Dec 10, 2019
Lexicon Pharmaceuticals
PR-M09-19-NI-032

Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi

Lexicon Pharmaceuticals

PR-M09-19-NI-032Sep 12, 2019
Visual Marketing Strategy for Libtayo
Marketing

Visual Marketing Strategy for Libtayo

Emilie Branch

Pharma's Almanac

PAO-M08-19-NI-005Aug 01, 2019
Sanofi
Market Growth

Sanofi Delivered Solid Growth in Q2 2019

Sanofi

PR-M07-19-NI-077-2322Jul 30, 2019
Sanofi
Influenza

Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu® in Flu Care

Sanofi

PR-M07-19-NI-061Jul 24, 2019
Voyager Therapeutics
Restructure

Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update

Voyager Therapeutics

PR-M06-19-NI-032Jun 20, 2019
Sanofi
Patent

Regeneron and Sanofi Strongly Disagree with Verdict Upholding Three of Five Amgen U.S. Patent Claims Relating to PCSK9 Antibodies

Sanofi

PR-M02-19-NI-059Feb 26, 2019
1 / 3